Ring-Sp1 decoy oligonucleotide effectively suppresses extracellular matrix gene expression and fibrosis of rat kidney induced by unilateral ureteral obstruction.
Tubulointerstitial fibrosis is the consequence of an injury characterized by the accumulation of excess collagen and other extracellular matrix components, resulting in the destruction of the normal kidney architecture and subsequent loss of function. A transcription factor Sp1, originally described as a ubiquitous transcription factor, is involved in the basal expression of extracellular matrix genes and may, therefore, be important in fibrotic processes. Here, we report on the design of a ring-Sp1 decoy oligonucleotide, containing the consensus Sp1 binding sequence in a single decoy molecule without an open end, to create a novel therapeutic strategy for fibrosis. The ring-Sp1 decoy oligonucleotide is highly resistant to degradation by nucleases or serum compared to the conventional phosphorothioated double-stranded Sp1 decoy oligonucleotide, and effectively suppressed the expression of transforming growth factor-beta1 and fibronectin, the binding of Sp1 to the promoter region of these genes, and proliferation in response to serum in normal rat kidney fibroblasts. Moreover, treatment with the ring-Sp1 decoy in vivo significantly attenuates extracellular matrix gene expression in the rat kidney in which a unilateral ureteral obstruction had been induced. These results suggest that the ring-Sp1 decoy oligonucleotide represents promising therapeutic alternative to the conventional treatment of fibrotic disorders.
Chae
Y-M
YM
Department of Pathology, Catholic University of Daegu School of Medicine, Daegu, Korea.
Park
K-K
KK
Lee
I-K
IK
Kim
J-K
JK
Kim
C-H
CH
Chang
Y-C
YC
D000818:Animals; D015152:Blotting, Northern / Q000379:methods; D002460:Cell Line; D049109:Cell Proliferation; D024202:Electrophoretic Mobility Shift Assay; D005109:Extracellular Matrix / Q000378:metabolism*; D005355:Fibrosis; D005818:Genetic Engineering; D015316:Genetic Therapy / Q000379:methods*; D007150:Immunohistochemistry / Q000379:methods; D007668:Kidney / Q000378:metabolism* / Q000473:pathology; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D016329:Sp1 Transcription Factor / Q000235:genetics*; D014162:Transfection / Q000379:methods; D016212:Transforming Growth Factor beta / Q000037:antagonists & inhibitors; D014517:Ureteral Obstruction / Q000378:metabolism* / Q000473:pathology
D016329:Sp1 Transcription Factor; D016212:Transforming Growth Factor beta